3rd Quarter - Termination

ORGANOVO, INC. for ORGANOVO, INC.

Period 3rd Quarter 2017 Filed Aug 31, 2017 Signed by Peter Rubin

Official filing
Firm
ORGANOVO, INC.
Client
ORGANOVO, INC.
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Sep 1, 2017

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the reauthorization of the Prescription Drug User Fee Act. Issues related to the implementation of PL 114-255, the 21st Century Cures Act.

LobbyistCovered position, as disclosed
PETER RUBIN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

Issues related to the FY 18 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts.

LobbyistCovered position, as disclosed
PETER RUBIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.